Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID-19 Pandemic in a Community Practice-Based Network.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
08 2021
Historique:
received: 15 12 2020
accepted: 20 04 2021
pubmed: 12 5 2021
medline: 10 8 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

The effect of the COVID-19 pandemic on community-based rheumatology care and the use of telehealth is unclear. We undertook this study to investigate the impact of the pandemic on rheumatology care delivery in a large community practice-based network. Using a community practice-based rheumatologist network, we examined trends in in-person versus telehealth visits versus canceled visits in 3 time periods: pre-COVID-19, COVID-19 transition (6 weeks beginning March 23, 2020), and post-COVID-19 transition (May-August). In the transition period, we compared patients who received in-person care versus telehealth visits versus those who cancelled all visits. We used multivariable logistic regression to identify factors associated with canceled or telehealth visits. Pre-COVID-19, there were 7,075 visits/week among 60,002 unique rheumatology patients cared for by ~300 providers practicing in 92 offices. This number decreased substantially (24.6% reduction) during the COVID-19 transition period for in-person visits but rebounded to pre-COVID-19 levels during the post-COVID-19 transition. There were almost no telehealth visits pre-COVID-19, but telehealth increased substantially during the COVID-19 transition (41.4% of all follow-up visits) and slightly decreased during the post-COVID-19 transition (27.7% of visits). Older age, female sex, Black or Hispanic race/ethnicity, lower socioeconomic status, and rural residence were associated with a greater likelihood of canceling visits. Most factors were also associated with a lower likelihood of having telehealth versus in-office visits. Patients living further from the rheumatologists' office were more likely to use telehealth. COVID-19 led to large disruptions in rheumatology care; these disruptions were only partially offset by increases in telehealth use and disproportionately affected racial/ethnic minorities and patients with lower socioeconomic status. During the COVID-19 era, telehealth continues to be an important part of rheumatology practice, but disparities in access to care exist for some vulnerable groups.

Identifiants

pubmed: 33973389
doi: 10.1002/acr.24626
pmc: PMC8212120
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1153-1161

Informations de copyright

© 2021, American College of Rheumatology.

Références

Health Care Manag (Frederick). 2015 Oct-Dec;34(4):337-49
pubmed: 26506296
Ann Rheum Dis. 2021 Feb;80(2):238-241
pubmed: 32963052
N Engl J Med. 2018 Jun 28;378(26):2456-2458
pubmed: 29949490
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
Ann Rheum Dis. 2020 Sep;79(9):1170-1173
pubmed: 32532753
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Ann Rheum Dis. 2020 Jul;79(7):859-866
pubmed: 32471903
JMIR Res Protoc. 2019 Sep 26;8(9):e14665
pubmed: 31573949
Stud Health Technol Inform. 2017;245:1223
pubmed: 29295310
Int J Rheum Dis. 2015 Mar;18(3):304-14
pubmed: 25530007
J Rheumatol. 2021 Apr;48(4):603-607
pubmed: 33191284
Rheumatology (Oxford). 2013 Jan;52(1):53-61
pubmed: 23192911
ACR Open Rheumatol. 2020 Jun;2(6):335-343
pubmed: 32311836
Semin Arthritis Rheum. 2016 Dec;46(3):380-385
pubmed: 27395561
Clin Rheumatol. 2021 Dec;40(12):5087-5093
pubmed: 34219187
ACR Open Rheumatol. 2021 Jan;3(1):17-24
pubmed: 33784021
Arthritis Care Res (Hoboken). 2020 Oct;72(10):1404-1409
pubmed: 31421020
Rheumatol Adv Pract. 2021 Nov 13;5(3):rkab073
pubmed: 34805737

Auteurs

Michael D George (MD)

University of Pennsylvania, Philadelphia.

Maria I Danila (MI)

University of Alabama at Birmingham.

Daniel Watrous (D)

Sierra Pacific Arthritis, Visalia, California.

Shanmugapriya Reddy (S)

Southwest Florida Rheumatology, Riverview.

Jeffrey Alper (J)

Medallion Clinical Research Institute, Naples, Florida.

Fenglong Xie (F)

University of Alabama at Birmingham.

W Benjamin Nowell (WB)

Global Healthy Living Foundation, Upper Nyack, New York.

Joel Kallich (J)

Massachusetts College of Pharmacy and Health Sciences University, Boston.

Cassie Clinton (C)

University of Alabama at Birmingham.

Kenneth G Saag (KG)

University of Alabama at Birmingham.

Jeffrey R Curtis (JR)

University of Alabama at Birmingham.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH